Browse articles from EyeWorld.org related to astigmatism. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ 510(k) clearance granted to pattern scanning laser indirect ophthalmoscope ➤ 12-week safety, efficacy results for wet AMD therapy ➤ Phase 3 trial for dry eye treatment complete ➤ Corneal implant company moves toward PMA submission ➤ Update on neuropathic corneal pain trial ➤ ASCRS news and events
Ophthalmology residents from Washington University in St. Louis reviewed “The effects of axis-flip of the refractive cylinder on vision and patient-reported outcome measures following toric intraocular lens implantation” from the Journal of Cataract & Refractive Surgery.
➤ First patient enrolled in Phase 3 trial evaluating phentolamine ophthalmic solution ➤ FDA clears IND amendment for Phase 3 retinitis pigmentosa gene therapy study ➤ Successful pre-submission meetings held for bioengineered corneal implants ➤ Study: AI chatbots pass ophthalmology board certification questions ➤ ASCRS news and events
The IC-8 Apthera IOL (Bausch + Lomb) is now available in the U.S., and several surgeons discussed how this technology fits in to their practice and for which patients.
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
➤ Positive Phase 3 results from trial investigating ocular pain, inflammation treatment ➤ Study evaluates use of sustained-release drug during Medicare pass-through program ➤ FDA approves treatment for geographic atrophy ➤ Dementia ‘much higher’ in patients with visual problems ➤ ASCRS news and events
➤ FDA approves NDA for IOP-lowering drug ➤ NDA submitted for presbyopia drop ➤ IND accepted for investigational treatment of persistent corneal epithelial defect ➤ Topline results from Phase 2 study of novel sedation drug for cataract surgery ➤ First patient enrolled in Phase 3 trial for investigational TED therapy ➤ Complimentary access to video journal ➤ ASCRS news and events
Two experts discussed the important topic of identifying astigmatism prior to cataract surgery: how to determine the level of astigmatism, when to address it, and how even low levels may have an impact.
➤ FDA approves first standalone MIGS device ➤ Phase 3 clinical study results for inflammation, pain management nanosuspension ➤ Phase 2a clinical trial begins for investigational MGD treatment ➤ Registry created to collect data on canaloplasty ➤ ASCRS news and events
“X-Rounds: Refractive Cataract Surgery to the Max” is a fast-paced session at the ASCRS Annual Meeting where members of the panel presented their answer to a question or thoughts on a topic in 2.5 minutes or less. The audience then voted for their favorite in each section.